Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315784581> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4315784581 endingPage "e408" @default.
- W4315784581 startingPage "e408" @default.
- W4315784581 abstract "Objective: Sacubitril/valsartan is a first-in-class, novel-acting, angiotensin receptor neprilysin inhibitor (ARNI) that provides inhibition of neprilysin and the angiotensin (AT1) receptor. Effects of Sacubitril/valsartan on carotid arterial IMT and elastic modulus, baPWV in hypertensive patients with heart failure Methods: Thirty-three hypertensive patients with chronic heart failure (mean age 79 years, male 15) were assigned to receive Sacubitril/valsartan (gradual increase depending on the condition) of Sacubitril/valsartan added to existing drug therapies (average number of antihypertensive agents 3) or switched from ARB or ACE inhibitor for 6 months. Changes in home BP, BNP, NT-proBNP, hANP, estimated glomerular filtration rate (eGFR), baPWV and central blood pressure (cSBP) were evaluated. EΘ was obtained by the phased-tracking method (Kanai, Circulation 2003). At four locations of bilateral common carotid arteries, IMT and Etheta; were measured simultaneously. Results: The basal values before Sacubitril/valsartan administration of Body weight(BW), BNP, NT-proBNP, hANP, EF, serum K, eGFR, home early morning blood pressure, home early morning heart rate, baPWV, cSBP, IMT, EΘ were 63 ± 16 kg and 310 ± 237 pg /,mL, 1981 ± 237 pg / mL, 475 ± 514 pg / mL, 51 ± 14%, 4.2 ± 0.4 mEq / L, 46 ± 14 ml / min / 1.73 m2, 141 ± 8/75 ± 11 mmHg, 76 ± 14 bpm, 1526 ± 245 cm / sec, 137 ± 13 mmHg, 0.84 ± 0.12 mm, and 301 ± 141 kPa respectively. ARNI s reduced BW (-4%), BNP (-32%), NT-proBNP (-38%), home early morning blood pressure-17 / -10mmHg, and baPWV (-4%) significantly (p < 0.05). In addition, EF (+ 5%) and hANP were significantly increased, and serum K and eGFR were unchanged. On the other hand, IMT (-5%) in carotid echo decreased, and EΘ decreased significantly. Conclusions: Sacubitril/valsartan was effective for BP control improved cardiac function and arterial stiffness in hypertensive patients with chronic heart failure. EΘ is a good surrogate marker for the early detection of vascular remodeling such as improvement of endothelial dysfunction prior to changes in IMT." @default.
- W4315784581 created "2023-01-13" @default.
- W4315784581 creator A5006085629 @default.
- W4315784581 date "2023-01-01" @default.
- W4315784581 modified "2023-10-05" @default.
- W4315784581 title "PS-C24-1: EFFECTS OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR ON CAROTID ARTERIAL IMT AND ELASTIC MODULUS, BAPWV IN HYPERTENSIVE PATIENTS WITH HEART FAILURE" @default.
- W4315784581 doi "https://doi.org/10.1097/01.hjh.0000916992.91003.6b" @default.
- W4315784581 hasPublicationYear "2023" @default.
- W4315784581 type Work @default.
- W4315784581 citedByCount "0" @default.
- W4315784581 crossrefType "journal-article" @default.
- W4315784581 hasAuthorship W4315784581A5006085629 @default.
- W4315784581 hasBestOaLocation W43157845811 @default.
- W4315784581 hasConcept C104826730 @default.
- W4315784581 hasConcept C104849204 @default.
- W4315784581 hasConcept C126322002 @default.
- W4315784581 hasConcept C134018914 @default.
- W4315784581 hasConcept C164705383 @default.
- W4315784581 hasConcept C181199279 @default.
- W4315784581 hasConcept C185592680 @default.
- W4315784581 hasConcept C2775850156 @default.
- W4315784581 hasConcept C2776754050 @default.
- W4315784581 hasConcept C2777387769 @default.
- W4315784581 hasConcept C2778198053 @default.
- W4315784581 hasConcept C2908929049 @default.
- W4315784581 hasConcept C55493867 @default.
- W4315784581 hasConcept C71924100 @default.
- W4315784581 hasConcept C84393581 @default.
- W4315784581 hasConceptScore W4315784581C104826730 @default.
- W4315784581 hasConceptScore W4315784581C104849204 @default.
- W4315784581 hasConceptScore W4315784581C126322002 @default.
- W4315784581 hasConceptScore W4315784581C134018914 @default.
- W4315784581 hasConceptScore W4315784581C164705383 @default.
- W4315784581 hasConceptScore W4315784581C181199279 @default.
- W4315784581 hasConceptScore W4315784581C185592680 @default.
- W4315784581 hasConceptScore W4315784581C2775850156 @default.
- W4315784581 hasConceptScore W4315784581C2776754050 @default.
- W4315784581 hasConceptScore W4315784581C2777387769 @default.
- W4315784581 hasConceptScore W4315784581C2778198053 @default.
- W4315784581 hasConceptScore W4315784581C2908929049 @default.
- W4315784581 hasConceptScore W4315784581C55493867 @default.
- W4315784581 hasConceptScore W4315784581C71924100 @default.
- W4315784581 hasConceptScore W4315784581C84393581 @default.
- W4315784581 hasIssue "Suppl 1" @default.
- W4315784581 hasLocation W43157845811 @default.
- W4315784581 hasLocation W43157845812 @default.
- W4315784581 hasOpenAccess W4315784581 @default.
- W4315784581 hasPrimaryLocation W43157845811 @default.
- W4315784581 hasRelatedWork W2263148019 @default.
- W4315784581 hasRelatedWork W2278230064 @default.
- W4315784581 hasRelatedWork W2616674787 @default.
- W4315784581 hasRelatedWork W2810662961 @default.
- W4315784581 hasRelatedWork W2920048038 @default.
- W4315784581 hasRelatedWork W2971294569 @default.
- W4315784581 hasRelatedWork W2972799805 @default.
- W4315784581 hasRelatedWork W2999054836 @default.
- W4315784581 hasRelatedWork W3032431997 @default.
- W4315784581 hasRelatedWork W4319600715 @default.
- W4315784581 hasVolume "41" @default.
- W4315784581 isParatext "false" @default.
- W4315784581 isRetracted "false" @default.
- W4315784581 workType "article" @default.